Teva Stock Highest Level: Why It Could Soar Further
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
VIX and daily volatility offer complementary views of risk. This overview explains how to interpret both for better timing and sizing.
21,595 articlesTeva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
A 64-year-old couple with $2.9 million in retirement assets faces a tight pre-Medicare year where a Roth conversion c...
JPMorgan raised its price target on Dell Technologies to 280 amid easing memory headwinds and a robust AI server back...
Ethereum hovers near a critical ceiling at $2,400 as May winds down, with a major upgrade and bank trading access in ...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
Portfolio manager Ben Carlson argues that avoiding big-ticket upgrades can shield households and portfolios from infl...
Investing in critical metals blends opportunity with policy risk. This guide breaks down how to evaluate this critica...
A suburban couple funds $80,000 into a donor-advised fund in 2026, capturing a decade of deductions at once and grant...
Analysts at Galaxy Digital see a clear path for the CLARITY Act to be signed into law by early August if Congress mai...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
The typical Social Security check in 2026 is $2,071 monthly, but taxes bite earlier than many retirees expect. A fres...
SBI Holdings moves to launch Japan's first spot XRP ETF, prioritizing XRP over Ethereum due to regulatory fit and a d...